Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Hydrocele Caused by Peritoneal Fluid Leakage Through Inguinal Canal.

Fernández P, De Arteaga J, Douthat W, Chiurchiu C, De La Fuente J.

Perit Dial Int. 2017 May-Jun;37(3):348-349. doi: 10.3747/pdi.2017.00015. No abstract available.

PMID:
28512168
2.

[Inadequate doses of hemodialysis. Predisposing factors, causes and prevention].

Fernández P, Núñez S, De Arteaga J, Chiurchiu C, Douthat W, De La Fuente J.

Medicina (B Aires). 2017;77(2):111-116. Spanish.

3.

Symptomatic Venous Thromboembolism and Major Bleeding After Renal Transplantation: Should We Use Pharmacologic Thromboprophylaxis?

Musso D, Robaina GI, Figueroa Córdoba AV, Martini GD, Albertini RA, Chiurchiu C, Tabares AH.

Transplant Proc. 2016 Oct;48(8):2773-2778. doi: 10.1016/j.transproceed.2016.07.022.

PMID:
27788816
4.

[The role of kidney transplantation in reducing mortality in a chronic dialysis program].

Douthat WG, Fernández P, Rechene J, Chiurchiu CR, De Arteaga J, Massari PU, De La Fuente J.

Medicina (B Aires). 2014;74(1):1-8. Spanish.

5.

High prevalence of secondary hyperparathyroidism in chronic kidney disease patients on dialysis in Argentina.

Douthat WG, Castellano M, Berenguer L, Guzmán MA, de Arteaga J, Chiurchiu CR, Massari PU, Garay G, Capra R, de La Fuente JL.

Nefrologia. 2013;33(5):657-66. doi: 10.3265/Nefrologia.pre2013.May.12009. English, Spanish.

6.

ADAMTS13 predicts renal and cardiovascular events in type 2 diabetic patients and response to therapy.

Rurali E, Noris M, Chianca A, Donadelli R, Banterla F, Galbusera M, Gherardi G, Gastoldi S, Parvanova A, Iliev I, Bossi A, Haefliger C, Trevisan R, Remuzzi G, Ruggenenti P; BENEDICT Study Group.

Diabetes. 2013 Oct;62(10):3599-609. doi: 10.2337/db13-0530. Epub 2013 Jun 3.

7.

[Associated factors and clinical implications of post transplant renal anemia].

Freiberg M, Chiurchiu C, Capra R, Eckhardt A, De La Fuente J, Douthat W, De Arteaga J, Massari PU.

Medicina (B Aires). 2013;73(2):136-40. Spanish. Erratum in: Medicina (B Aires). 2013;73(4):396.

8.

Measurable urinary albumin predicts cardiovascular risk among normoalbuminuric patients with type 2 diabetes.

Ruggenenti P, Porrini E, Motterlini N, Perna A, Ilieva AP, Iliev IP, Dodesini AR, Trevisan R, Bossi A, Sampietro G, Capitoni E, Gaspari F, Rubis N, Ene-Iordache B, Remuzzi G; BENEDICT Study Investigators.

J Am Soc Nephrol. 2012 Oct;23(10):1717-24. Epub 2012 Aug 30.

9.

CKD-EPI instead of MDRD for candidates to kidney donation.

Lujan PR, Chiurchiu C, Douthat W, de Arteaga J, de la Fuente J, Capra RH, Massari PU.

Transplantation. 2012 Sep 27;94(6):637-41.

PMID:
22918217
10.

New options for the management of hyperparathyroidism after renal transplantation.

Douthat WG, Chiurchiu CR, Massari PU.

World J Transplant. 2012 Jun 24;2(3):41-5. doi: 10.5500/wjt.v2.i3.41. Review.

11.

Expanded criteria donors, histological scoring, and prolonged cold ischemia: impact on renal graft survival.

Chiurchiu C, Riva V, Bürgesser MV, de Arteaga J, Douthat W, de la Fuente J, de Diller AB, Massari PU.

Transplant Proc. 2011 Nov;43(9):3312-4. doi: 10.1016/j.transproceed.2011.09.085.

PMID:
22099786
12.

High-dose steroid treatment increases free water transport in peritoneal dialysis patients.

de Arteaga J, Ledesma F, Garay G, Chiurchiu C, de la Fuente J, Douthat W, Massari P, Terryn S, Devuyst O.

Nephrol Dial Transplant. 2011 Dec;26(12):4142-5. doi: 10.1093/ndt/gfr533. Epub 2011 Sep 22.

PMID:
21940485
13.

Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: the delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial.

Ruggenenti P, Lauria G, Iliev IP, Fassi A, Ilieva AP, Rota S, Chiurchiu C, Barlovic DP, Sghirlanzoni A, Lombardi R, Penza P, Cavaletti G, Piatti ML, Frigeni B, Filipponi M, Rubis N, Noris G, Motterlini N, Ene-Iordache B, Gaspari F, Perna A, Zaletel J, Bossi A, Dodesini AR, Trevisan R, Remuzzi G; DEMAND Study Investigators.

Hypertension. 2011 Nov;58(5):776-83. doi: 10.1161/HYPERTENSIONAHA.111.174474. Epub 2011 Sep 19.

14.

Use of percutaneous ethanol injection therapy for recurrent secondary hyperparathyroidism after subtotal parathyroidectomy.

Douthat WG, Cardozo G, Garay G, Orozco S, Chiurchiu C, de la Fuente J, de Arteaga J, Massari PU.

Int J Nephrol. 2011;2011:246734. doi: 10.4061/2011/246734. Epub 2011 Jun 4.

15.

Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trial.

Ruggenenti P, Fassi A, Ilieva A, Iliev IP, Chiurchiu C, Rubis N, Gherardi G, Ene-Iordache B, Gaspari F, Perna A, Cravedi P, Bossi A, Trevisan R, Motterlini N, Remuzzi G; BENEDICT-B Study Investigators.

J Hypertens. 2011 Feb;29(2):207-16.

PMID:
21243736
16.

[Renal abnormalities in HIV infected patients].

Pernasetti MM, Chiurchiu C, Fuente Jde L, Arteaga Jd, Douthat W, Bardosy C, Zarate A, Massari PU.

Medicina (B Aires). 2010;70(3):247-53. Spanish.

PMID:
20529774
17.

Effect of the urotensin receptor antagonist palosuran in hypertensive patients with type 2 diabetic nephropathy.

Vogt L, Chiurchiu C, Chadha-Boreham H, Danaietash P, Dingemanse J, Hadjadj S, Krum H, Navis G, Neuhart E, Parvanova AI, Ruggenenti P, Woittiez AJ, Zimlichman R, Remuzzi G, de Zeeuw D; PROLONG (PROteinuria Lowering with urOteNsin receptor antaGonists) Study Group.

Hypertension. 2010 May;55(5):1206-9. doi: 10.1161/HYPERTENSIONAHA.109.149559. Epub 2010 Mar 15.

18.

Thrombophilic mutations: no association with thrombotic events in renal transplant recipients.

Chiurchiu C, de Alvarellos T, Sanchez A, Cortiñas D, Douthat W, de la Fuente J, de Arteaga J, Massari PU.

Transplant Proc. 2010 Jan-Feb;42(1):282-3. doi: 10.1016/j.transproceed.2009.11.033.

PMID:
20172331
19.

Results of the conversion to everolimus in renal transplant recipients with posttransplantation malignancies.

Chiurchiu C, Carreño CA, Schiavelli R, Petrone H, Balaguer C, Trimarchi H, Pujol GS, Novoa P, Acosta F, González C, Arriola M, Massari PU; Argentinian Registry of Everolimus Treated Renal Transplant Recipients.

Transplant Proc. 2010 Jan-Feb;42(1):277-9. doi: 10.1016/j.transproceed.2009.11.017.

PMID:
20172329
20.

Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICT.

De Cosmo S, Motterlini N, Prudente S, Pellegrini F, Trevisan R, Bossi A, Remuzzi G, Trischitta V, Ruggenenti P; BENEDICT Study Group.

Diabetes. 2009 Dec;58(12):2920-9. doi: 10.2337/db09-0407. Epub 2009 Aug 31.

Supplemental Content

Loading ...
Support Center